Youle M - Search Results

1

Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment.

Schrooten W, Colebunders R, Youle M, Molenberghs G, Dedes N, Koitz G, Finazzi R, de Mey I, Florence E, Dreezen C; Eurosupport Study Group. Schrooten W, et al. Among authors: youle m. AIDS. 2001 May 25;15(8):1019-23. doi: 10.1097/00002030-200105250-00010. AIDS. 2001. PMID: 11399984 Clinical Trial.

2

Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population. Royal Free Centre for HIV Medicine.

Mocroft A, Devereux H, Kinloch-de-Loes S, Wilson D, Madge S, Youle M, Tyrer M, Loveday C, Phillips AN, Johnson MA. Mocroft A, et al. Among authors: youle m. AIDS. 2000 Jul 28;14(11):1545-52. doi: 10.1097/00002030-200007280-00010. AIDS. 2000. PMID: 10983641 Clinical Trial.

3

Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?

Antiretroviral Therapy Cohort Collaboration (ART-CC); Mugavero MJ, May M, Harris R, Saag MS, Costagliola D, Egger M, Phillips A, Günthard HF, Dabis F, Hogg R, de Wolf F, Fatkenheuer G, Gill MJ, Justice A, D'Arminio Monforte A, Lampe F, Miró JM, Staszewski S, Sterne JA. Antiretroviral Therapy Cohort Collaboration (ART-CC), et al. AIDS. 2008 Nov 30;22(18):2481-92. doi: 10.1097/QAD.0b013e328318f130. AIDS. 2008. PMID: 19005271 Free PMC article.

4

The potential for CD4 cell increases in HIV-positive individuals who control viraemia with highly active antiretroviral therapy.

Smith CJ, Sabin CA, Lampe FC, Kinloch-de-Loes S, Gumley H, Carroll A, Prinz B, Youle M, Johnson MA, Phillips AN. Smith CJ, et al. Among authors: youle m. AIDS. 2003 May 2;17(7):963-9. doi: 10.1097/00002030-200305020-00004. AIDS. 2003. PMID: 12700445

5

Raised viral load in patients with viral suppression on highly active antiretroviral therapy: transient increase or treatment failure?

Moore AL, Youle M, Lipman M, Cozzi-Lepri A, Lampe F, Madge S, Nesaratnam S, Tyrer M, Cuthbertson Z, Ransom D, Loveday C, Johnson MA, Phillips AN; Royal Free Centre for HIV Medicine. Moore AL, et al. Among authors: youle m. AIDS. 2002 Mar 8;16(4):615-8. doi: 10.1097/00002030-200203080-00013. AIDS. 2002. PMID: 11873005

6

Changes in CD4 lymphocyte counts after interruption of therapy in patients with viral failure on protease inhibitor-containing regimens. Royal Free Centre for HIV Medicine.

Youle M, Janossy G, Turnbull W, Tilling R, Loveday C, Mocroft A, Tyrer M, Madge S, Wilson D, Dykhoff A, Johnson M, Phillips AN. Youle M, et al. AIDS. 2000 Aug 18;14(12):1717-20. doi: 10.1097/00002030-200008180-00005. AIDS. 2000. PMID: 10985307

7

Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment-Experienced People Living With Human Immunodeficiency Virus.

Greenberg L, Ryom L, Neesgaard B, Wandeler G, Staub T, Gisinger M, Skoll M, Günthard HF, Scherrer A, Mussini C, Smith C, Johnson M, De Wit S, Necsoi C, Pradier C, Wit F, Lehmann C, d'Arminio Monforte A, Miró JM, Castagna A, Spagnuolo V, Sönnerborg A, Law M, Hutchinson J, Chkhartishvili N, Bolokadze N, Wasmuth JC, Stephan C, Vannappagari V, Rogatto F, Llibre JM, Duvivier C, Hoy J, Bloch M, Bucher HC, Calmy A, Volny Anne A, Pelchen-Matthews A, Lundgren JD, Peters L, Bansi-Matharu L, Mocroft A; RESPOND (International Cohort Consortium of Infectious Diseases) Study Group. Greenberg L, et al. Clin Infect Dis. 2021 Oct 5;73(7):e2323-e2333. doi: 10.1093/cid/ciaa1878. Clin Infect Dis. 2021. PMID: 33354721 Free PMC article.

8

Tuberculosis among people with HIV infection in the United Kingdom: opportunities for prevention?

Grant AD, Bansi L, Ainsworth J, Anderson J, Delpech V, Easterbrook P, Fisher M, Gazzard B, Gilson R, Gompels M, Hill T, Johnson M, Leen C, Orkin C, Phillips AN, Porter K, Post F, Walsh J, Sabin CA; United Kingdom Collaborative HIV Cohort Study Group. Grant AD, et al. AIDS. 2009 Nov 27;23(18):2507-15. doi: 10.1097/QAD.0b013e3283320dfd. AIDS. 2009. PMID: 19770622

9

Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre.

Mocroft A, Youle M, Moore A, Sabin CA, Madge S, Lepri AC, Tyrer M, Chaloner C, Wilson D, Loveday C, Johnson MA, Phillips AN. Mocroft A, et al. Among authors: youle m. AIDS. 2001 Jan 26;15(2):185-94. doi: 10.1097/00002030-200101260-00007. AIDS. 2001. PMID: 11216926

10

Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers.

Sabin CA, Smith CJ, Youle M, Lampe FC, Bell DR, Puradiredja D, Lipman MC, Bhagani S, Phillips AN, Johnson MA. Sabin CA, et al. Among authors: youle m. AIDS. 2006 Jan 2;20(1):67-71. doi: 10.1097/01.aids.0000196178.73174.24. AIDS. 2006. PMID: 16327321

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters